Whole human blood
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified: > Other: > Other > Whole human blood
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 3002.90.52.10
Whole Human Blood for Transfusion
Whole human blood collected from donors, anticoagulated, and prepared for direct transfusion into patients experiencing acute blood loss or anemia. It falls under HTS 3002.90.52.10 as whole human blood intended for therapeutic uses without separation into components like plasma or platelets.
Anticoagulated Whole Human Blood Units
Standard 450-500mL units of human whole blood treated with CPD or CPDA-1 anticoagulant, stored in PVC blood bags for emergency transfusions. Classified under HTS 3002.90.52.10 as unmodified whole human blood for therapeutic transfusion purposes.
O-Negative Whole Human Blood for Emergencies
Universal donor O-negative whole human blood, group-typed and cross-matched, for immediate use in trauma cases without compatibility testing. HTS 3002.90.52.10 covers this as therapeutic whole human blood not separated into fractions.
Irradiated Whole Human Blood for Immunocompromised Patients
Gamma-irradiated whole human blood to prevent graft-vs-host disease in transplant or cancer patients, qualifying as therapeutic whole human blood under HTS 3002.90.52.10.
Leukoreduced Whole Human Blood
Whole human blood with leukocytes filtered to <5x10^6 per unit to reduce transfusion reactions, still classified as whole blood under HTS 3002.90.52.10 since primary components remain intact.